This article is more than 5 years old. Information may no longer be current.
Society presents awards to MD Anderson professor
Click Here to Manage Email Alerts
The British Pharmacological Society presented the Sir James Black Award to V. Craig Jordan, PhD.
The award recognizes scientists for discoveries of important principles for drug treatment.
V. Craig Jordan
Jordan, a professor in the department of breast medical oncology at The University of Texas MD Anderson Cancer Center, was the first to discover the preventive abilities of tamoxifen and raloxifene. The medicines are approved by the FDA to reduce breast cancer incidence in high-risk women.
“This is indeed a tremendous honor and further recognition of Dr. Jordan’s historic contributions to cancer therapeutics,” Ethan Dmitrovsky, MD, executive vice president and provost at MD Anderson, said in a press release. “It is an award well-deserved and I commend Dr. Jordan on this major achievement.”
Jordan, who joined MD Anderson in 2014, focuses on the new biology of estrogen-induced cell death with the goal of developing translational approaches for treating and preventing cancer.
He is a visiting professor of molecular medicine at University of Leeds in England, and an adjunct professor of molecular pharmacology and biological chemistry at Northwestern University. He previously served as scientific director of the Lombardi Comprehensive Cancer Center at Georgetown University.